Skip to main content
. 2022 Sep 20;9:984711. doi: 10.3389/fcvm.2022.984711

Table 4.

Subgroup analysis for cardiovascular mortality for logRC and RC (continuous variables).

LogRC P p-int RC, mg/dL RC, mmol/L P p-int
HR (95% CI) HR (95% CI) HR (95% CI)
Age <0.001 0.025
≥65 years 9.33 (3.22, 27.09) <0.001 1.01 (1.01, 1.02) 1.49 (1.22, 1.82) <0.001
<65 years 0.57 (0.16, 1.95) 0.369 0.99 (0.97, 1.01) 0.67 (0.31, 1.44) 0.305
Sex 0.080 0.158
Male 4.63 (1.68, 12.77) 0.003 1.01 (1.00, 1.02) 1.50 (1.19, 1.87) 0.001
Female 0.96 (0.21, 4.49) 0.960 1.00 (0.98, 1.02) 0.93 (0.42, 2.07) 0.867
Diabetes 0.086 0.112
Yes 5.36 (1.61, 17.82) 0.006 1.01 (1.00, 1.01) 1.44 (1.17, 1.77) 0.001
No 1.27 (0.39, 4.15) 0.692 1.00 (0.98, 1.01) 0.88 (0.45, 1.71) 0.699
Hypertension 0.803 0.705
Yes 3.08 (1.10, 8.62) 0.032 1.01 (1.00, 1.02) 1.45 (1.15, 1.82) 0.002
No 3.39 (0.60, 19.24) 0.169 1.01 (0.99, 1.02) 1.24 (0.65, 2.36) 0.510
Smoking 0.530 0.632
Yes 3.41 (1.19, 9.77) 0.022 1.01 (1.00, 1.02) 1.42 (1.12, 1.80) 0.004
No 1.97 (0.47, 8.34) 0.356 1.01 (0.99, 1.02) 1.25 (0.74, 2.12) 0.408

HR, hazard ratio; CI, confidence interval; p-int, p for interaction. Adjusted for age + sex + race + antihypertensive medications + lipid-lowering medications use + systolic blood pressure + coronary heart disease + stroke + smoking.